New anti-biofilm compounds show promise against drug-resistant bacteria linked to hospital infections

February 16, 2016 by Ian Demsky, University of Michigan

Researchers at the University of Michigan Life Sciences Institute and School of Public Health have discovered a new class of anti-biofilm compounds derived from marine microorganisms that show promise against a drug-resistant bacterium commonly associated with hospital-acquired infections.

In cell cultures, the new compounds, known as cathuitamycins, are able to stop the Acinetobacter baumannii bacteria from gathering together in a sticky cluster known as a biofilm, according to findings scheduled to be published Feb. 16 in Nature Communications. Biofilms cling to surfaces and form complex structures that make them far more resistant to drugs than free-floating bacteria.

This property makes biofilms a deadly risk to patients in a hospital setting, where they can cling to medical devices, prosthetic implants and other surfaces, making them resistant to sterilization with traditional antimicrobial agents.

There are currently no drugs that specifically target on the market or in clinical trials, the researchers noted.

"This is why preventing biofilm formation is such an important research target," said Ashootosh Tripathi, a research fellow in the lab of LSI faculty member David Sherman. Tripathi was co-first author of the study, along with Sung Ryeol Park, a former postdoctoral research fellow in the Sherman lab.

Moreover, A. baumannii's resistance to front-line antibiotics has been a growing concern worldwide and this bacterium can form a biofilm easily, which makes the treatment even more challenging, said co-senior author Chuanwu Xi, associate professor of at the U-M School of Public Health.

Treatment of (multidrug resistant A. baumannii) infections is a great challenge for physicians as is control of MDRAB spread, according to a recent article in the International Journal of Environmental Research and Public Health.

The new anti-biofilm agents were discovered by conducting high-throughput screening of compounds in the LSI's library of "natural product" extracts—which includes thousands of drug-like substances derived from collected by Sherman and his collaborators during marine field collection expeditions in locations across the globe.

These particular compounds were derived from the bacterium Streptomyces gandocaensis, which was isolated from marine sediment collected on a 2007 expedition to Punta Mona Island in Costa Rica. The screening was conducted in the LSI's high-throughput lab, the Center for Chemical Genomics.

Once an extract was found that inhibited A. baumannii's ability to form biofilms, the researchers conducted experiments to find its most potent forms; they also created two new more potent analogs.

Anti-biofilm drugs might be applied either directly to objects like medical implants, catheters or dental implants, or through systemic application, like antibiotics. Still in its early stages, the discovery will need further compound optimization and preclinical development before human clinical trials could be considered.

"This new class of biofilm inhibitors provides a foundation toward the development of safe and effective drugs to limit or prevent biofilm formation," said Sherman, co-senior author of the study and the Hans W. Vahlteich Professor of Medicinal Chemistry and associate dean for research and graduate education at the U-M College of Pharmacy, professor of chemistry in the College of Literature, Science, and the Arts, and of microbiology and immunology in the Medical School.

"As antibiotic resistance becomes an increasingly important global health concern, marine microorganisms have a great—and largely untapped—potential to provide new classes of antibiotics and anti-biofilm compounds."

Explore further: New technique could prevent biofilms on catheters and medical implants

Related Stories

New technique could prevent dangerous biofilms on catheters

November 17, 2015

Biofilms frequently coat the surfaces of catheters, and of various medical implants and prostheses, where they can cause life-threatening infections. New research at the Sahlgrenska Academy show that coating implants with ...

Antibiotics give rise to new communities of harmful bacteria

February 23, 2015

Most people have taken an antibiotic to treat a bacterial infection. Now researchers from the University of North Carolina at Chapel Hill and the University of San Diego, La Jolla, reveal that the way we often think about ...

Recommended for you

In colliding galaxies, a pipsqueak shines bright

February 20, 2019

In the nearby Whirlpool galaxy and its companion galaxy, M51b, two supermassive black holes heat up and devour surrounding material. These two monsters should be the most luminous X-ray sources in sight, but a new study using ...

When does one of the central ideas in economics work?

February 20, 2019

The concept of equilibrium is one of the most central ideas in economics. It is one of the core assumptions in the vast majority of economic models, including models used by policymakers on issues ranging from monetary policy ...

Research reveals why the zebra got its stripes

February 20, 2019

Why do zebras have stripes? A study published in PLOS ONE today takes us another step closer to answering this puzzling question and to understanding how stripes actually work.

Correlated nucleons may solve 35-year-old mystery

February 20, 2019

A careful re-analysis of data taken at the Department of Energy's Thomas Jefferson National Accelerator Facility has revealed a possible link between correlated protons and neutrons in the nucleus and a 35-year-old mystery. ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.